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Abstract 
Stress is known to correlate with the incidence of acute myocardial infarction; 
however, the molecular mechanisms underlying this correlation are not known. This 
study was designed to assess the effect of experimental stress on arterial thrombus 
formation, the key event in acute myocardial infarction. Mice exposed to 20 hours of 
restraint stress displayed an increased arterial prothrombotic potential as assessed 
by photochemical injury-induced time to thrombotic occlusion. This increase was 
prevented by chemical sympathectomy performed through 6-hydroxydopamine 
(OHDA). Blood-born tissue factor activity was enhanced by stress and this increase 
could be prevented by OHDA treatment. Vessel wall tissue factor, platelet count, 
platelet aggregation, coagulation times (PT, aPTT), fibrinolytic system (t-PA and PAI-
1), and tail bleeding time remained unaltered. Telemetric analysis revealed only 
minor hemodynamic changes throughout the stress protocol. Plasma catecholamines 
remained unaffected after restraint stress. TNF-α plasma levels were unchanged and 
inhibition of TNF-α had no effect on stress-enhanced thrombosis. These results 
indicate that restraint stress enhances arterial thrombosis via the sympathetic 
nervous system. Blood-borne tissue factor contributes, at least in part, to the 
observed effect whereas vessel wall tissue factor, platelets, circulating coagulation 
factors, fibrinolysis, and inflammation do not appear to play a role. These findings 
shed new light on the understanding of stress-induced cardiovascular events. 
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Introduction 
In modern society, people are frequently faced with stressful situations. Several 
lines of evidence (Rosengren et al., 2004) demonstrate a correlation between stress 
and cardiovascular events. However, the mechanisms accounting for these stress-
related incidents are not well understood. 
The sympathetic nervous system (SNS) is one of the most intensely studied 
pathways mediating responses to stress and has been accounted for the increased 
vascular morbidity and mortality in response to several stressors (Nawrot et al., 
2011). Arterial thrombus formation is the critical step in acute cardiovascular events 
such as myocardial infarction (Ross, 1999), and tissue factor (TF) is a key trigger of 
thrombus formation in vivo (Steffel et al., 2006). In addition, inflammation and in 
particular cytokines such as tumor necrosis factor alpha (TNF-α) (Yamamoto et al., 
2002) have been proposed as potential mediators of stress related vascular events 
as have other components of the coagulation cascade as well as platelets (Larsson 
et al., 1989). 
Restraint stress is a long established model of experimental stress for rodents 
(Glavin et al., 1994) and allows for the characterization of the involved mechanisms 
(Yamamoto et al., 2002). To that end, we measured in vivo real-time arterial 
thrombus formation (Stampfli et al., 2010) in stressed mice. To assess the role of the 
SNS, we used 6-hydroxydopamine (OHDA), a highly specific blocker of the 
sympathetic nervous system. This procedure, known as chemical sympathectomy 
(Finch et al., 1972), leads to destruction of the postsynaptic sympathetic neurons.  
Since TNF-α has been proposed as a potential mediator of stress related vascular 
events (Yamamoto et al., 2002), the role of TNF-α was assessed using etanercept, a 
highly specific soluble blocking receptor for TNF-α, which has been proven to reliably 
inhibit TNF-α in vivo in C57Bl/6 mice (Hui-Yuen et al., 2006). 
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Methods 
Animals 
Age matched male C57Bl/6 mice were randomly assigned to control conditions 
or restraint stress. Mice were bred and housed in a specific pathogen free (SPF) 
animal facility with conventional light cycle at the Institute of Laboratory Animal 
Science, University of Zurich. All experiments were approved by the Veterinary Office 
and the Department of Health of the Canton of Zurich, Switzerland. 
Stress protocol 
Mice were placed into 50-mL conical centrifuge tubes fitted with multiple 
punctures allowing ventilation and water uptake. Tubes were placed in horizontal 
holders inside a standard cage housed in the animal facility with conventional light 
cycle. Water was provided ad libitum to the animals during the entire procedure. After 
20 hours of restraint stress (Yamamoto et al., 2002), mice were anesthetized without 
delay and exposed to the arterial thrombosis protocol(Stampfli et al., 2010). After 
cessation of the experiment, animals were euthanized by pentobarbital overdose 
injection and relevant organs were excised. All groups were food deprived 20 hours 
prior to the thrombosis experiment. 
Arterial thrombosis  
A separate set of mice was anesthetized with pentobarbital (87 mg/kg i.p.). 
Rose bengal (Fisher Scientific, Fair Lawn, NJ) was injected into the tail vein in a 
volume of 0.12 ml at a concentration of 50 mg/kg body weight. Mice were placed 
under a dissecting microscope and the right common carotid artery was exposed 
following a midline cervical incision. A Doppler flow probe (Model 0.5 VB, Transonic 
Systems, Ithaca, NY) was applied and connected to a flowmeter (Transonic, Model 
T106) supplying a data acquisition system (PowerLab 4/30, AD Instruments). A 1.5-
mW green light laser (540 nm) (Melles Griot, Carlsbad, CA) was directed at the 
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desired site of injury at a distance of 6 cm for 60 minutes or until complete occlusion. 
Flow was monitored real-time for 120 minutes from the onset of injury. Occlusion was 
defined as flow ≤0.1 mL/min for at least 1 minute (Camici et al., 2006). Data were 
analyzed with ChartPro Software (AD Instruments). Organs of these mice were not 
harvested for further analysis (except for the carotid arteries, which were isolated for 
histologic assessment). 
OHDA treatment 
OHDA treatment was performed with 6-Hydroxydopamine hydrobromide 
(Sigma-Aldrich, Buchs, Switzerland) as previously described (Kohm & Sanders, 
1999); OHDA was dissolved in 0.5 M saline containing 1 mM ascorbate as an 
antioxidant. Mice were treated by i.p.-injections (200 mg/kg body weight) 6, 4, and 2 
days before the stress protocol. In control groups, vehicle injections (0.5 M saline 
containing 1 mM ascorbate without OHDA) were performed at the same time points 
with the same volume as for OHDA treated mice. 
Telemetric assessment of blood pressure and heart rate 
A separate set of mice was used for this experiment. After anesthesia with 
xylazin and ketamin, shaving and disinfecting the neck, the left common carotid 
artery was exposed. The transmitter’s catheter was inserted into the artery and 
pushed forward until the tip just entered the thoracic aorta. The transmitter body was 
fixed under the skin. Blood pressure transmitter implantation was carried out under 
aseptic conditions. Mice were allowed to recover for 2 weeks. Measurements were 
performed using a TA11PA-C10 transmitter (Data Sciences International, Tilburg, 
The Netherlands). After implantation and recovery period, parameters were 
measured telemetrically (without any additional handling) in all groups. After 
termination of 20 hours measurement, mice were euthanized by pentobarbital 
overdose. Data was generated and analyzed by using Dataquest A.R.T 3.0 software 
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(Data Sciences International, Tilburg, The Netherlands). Organs of these mice were 
not harvested for further analysis. 
Catecholamine measurement 
Mice were taken out of their cage or the restraint tube, immediately anesthetized 
with pentobarbital (87 mg/kg i.p.), and put in a separate cage for 2 minutes to allow 
full effect of the drug. Then, intracardial blood was drawn without any further 
manipulation. Citrated blood samples were centrifuged at 3000 rpm for 10 min at 
4°C. Subsequently, plasma was collected and quickly frozen at -80°C for a maximum 
of 7 days until catecholamine measurements were performed by HPLC with 
amperometric detection: plasma (120 µl) or standard with dihydroxybenzylamine 
(DHBA, Sigma Aldrich, Frankfurt, Germany) as internal standard was extracted on 
activated alumina at pH 8.6. The alumina was allowed to settle and the supernatant 
aspirated followed by three washes with water. The catecholamines were then eluted 
with 130 µl of a mixture of acetic acid 0.2 M and phosphoric acid 0.04 M (8/2, v/v) 
and 100 µl was injected into the chromatography system. The separation was 
achieved on a reversed-phase column Nucleosil 5µm C-18, 25 cm × 4.6 mm 
(Macherey-Nagel AG, Oensingen, Switzerland) using a 50 mM sodium acetate buffer 
mobile phase containing 20 mM citric acid, 0.135 mM EDTA, 1 mM dibutylamine and 
3.8 mM sodium octyl sulfonate, as an ion-pairing agent, and 7% methanol at a flow 
rate of 0.7 ml/min. The electrochemical detector (from Antec, model Decade) was set 
at + 0.8 V. The following order of elution was observed: NA, A, DHBA and dopamine. 
The recovery was 80% and the quantification limit was 5 pg per injection. The 
interassay coefficients of variation were 11% for NA and 12% for A. 
Tissue factor activity  
Carotid arteries were homogenized in 50 µl of lysis buffer (50 mM Tris-HCl, 100 
mM NaCl, 0.1% Triton-X 100, pH 7.4) by manual grinding on ice. Samples were then 
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centrifuged at 14000 rpm for 15 min at 4°C and the supernatant was transferred to a 
fresh tube. For blood-borne TF activity citrated blood (3.2% citrate 1/10) was 
harvested by puncture of the right ventricle. Plasma was extracted by 15 minutes 
centrifugation at 2500G and stored immediately at -80 °C until analysis. TF activity 
was assessed with a colorimetric assay (Actichrome TF, American Diagnostica); 
incubation at 37°C allowed TF to form a complex with FVII and this complex to 
cleave FX to FXa. Absorbance was determined at 405 nm and compared to a 
standard curve generated using known amounts of lyophilized TF (Stampfli et al., 
2010).  
Platelet aggregation 
Platelet aggregation was studied in fresh citrated blood within 1 h using a 
Chrono-Log whole blood impedance aggregometer (Chrono-Log, Havertown, PA, 
USA). Platelets were equilibrated under constant stirring for 1 min prior to addition of 
thrombin (0.5 U/mL; Sigma Aldrich, Frankfurt, Germany). Aggregation was displayed 
as a function of time (AGGRO/LINK Software; Chrono-Log). 
Tail bleeding time 
Tail bleeding time was assessed as described previously (Renne et al., 2005). 
After anesthetizing mice (87 mg/kg body weight, i.p.), the distal 3-mm segment of the 
tail was removed with a scalpel. Bleeding was monitored by gently absorbing the 
blood with a filter paper at 15-s intervals without touching the wound.  
Platelet count 
Platelets were counted in fresh whole blood collected in EDTA tubes using an 
automated cell counter ScilVet abc plus with impedance technology (Horiba 
Instruments, Darmstadt, Germany). 
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PT, aPTT 
Prothrombin time (PT) and partial thromboplastin time (aPTT) measurements 
were conducted by using the Start4 analyzer (Diagnostica Stago, France) with the 
according reagents (Roche Diagnostics, Switzerland). Briefly, PT assessed fibrin 
formation in plasma triggered by the addition of exogenous TF, thus testing the 
coagulation factors downstream of TF. aPTT also assessed fibrin formation, but this 
time triggered by the addition of kaolin, which led to contact activation of the intrinsic 
pathway. In both tests calcium was added to the plasma. 
Plasminogen activator inhibitor ELISA 
Plasminogen activator inhibitor (PAI) 1 antigen was determined in citrated 
plasma using a PAI-1 functional assay ELISA kit (Oxford Biomedical Research, 
Oxford MI, USA) according to the manufacturer’s instructions. 
Real-time PCR 
Carotid arteries were snap frozen in liquid nitrogen and stored at -80°C until 
use. Total RNA was isolated using TRIzol reagent (Invitrogen). cDNA was generated 
using Ready-To-Go You-Prime First-Strand Beads (Amersham Bioscience) and first-
strand cDNA primer pd(N)6. Real-time PCR was performed using SybrGreen Jump 
start kit (Sigma). Murine primers were as follows: TF: forward (5-3: 
CAATGAATTCTCGATTGATGTGG) and reverse (5-3: 
GGAGGATGATAAAGATGGTGGC). Tissue plasminogen activator (tPA): forward (5-
3: TGAGCCAACGCAGACAACTTA) and reverse (5-3: 
TGACAGCACCCAGCAGGAACT). Data were normalized to murine S12: forward (5-
3: GAAGCTGCCAAAGCCTTAGA) and reverse (5-3: 
AACTGCAACCAAAACCCTTC). The amplification program consisted of 1 cycle at 
95˚C for 10 min, followed by 40 cycles with a denaturing phase at 95˚C for 30 s, an 
annealing phase of 1 min at 60˚C and an elongation phase at 72˚C for 1 min. For 
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verification of the correct amplification, PCR products were analyzed on an ethidium 
bromide stained 1,5% agarose gel. Quantification was performed using 2-ΔΔCt 
method. 
Etanercept treatment 
Etanercept (Enbrel®; Amgen, Switzerland) was dissolved in the supplied vehicle 
according to the manufacturer’s instructions and diluted in sterile PBS. Mice were 
given an i.p. dose of 10 mg/kg 24 hours (Hui-Yuen et al., 2006) prior to the start of 
the stress protocol. Control mice were injected with the same amount of vehicle and 
PBS at the same time. 
Immunohistochemistry 
Carotid arteries were mounted in optimal cutting temperature (Tissue-Tek). 
Specimens were cut into 8-µm sections and fixed with 4% paraformaldehyde. 
Sections were stained with oil red O for 1 hour at room temperature. For the 
assessment of CD68 (Serotec; primary antibody dilution 1:400), CD3 (Serotec; 
primary antibody 1:100), VCAM-1 (Serotec; primary antibody 1:200), E-selectin (BD 
Pharmingen; primary antibody 1:25), and P-selectin (BD Pharmingen; primary 
antibody 1:50) sections were fixed in acetone, blocked with 1% FCS, and incubated 
with the specific rat anti-mouse primary antibody. The primary antibodies were 
revealed by goat anti-rat immunoglobulin antibodies (Caltag Laboratories; secondary 
antibody 1:150), followed by alkaline phosphatase-labeled donkey anti-goat 
antibodies (Jackson Immunoresearch; dilution 1:80). Alkaline phosphatase was 
visualized using naphthol AS-BI phosphate and new fuchsin as substrate. Sections 
were counterstained with hemalum and coverslipped. Atherosclerotic plaques served 
as positive control and primary murine IgG1 antibody as negative control. From each 
specimen, 6 sections in a distance of 100 µm from each other were analyzed. CD68 
positive cells in the intimal and medial layer were counted in each cross-section and 
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mean numbers were calculated for each specimen under blind conditions. For 
VCAM-1, percentages of stained area were quantified with the AnalysisFIVE 
program. 
Statistical analysis 
Data are represented as mean ± SEM. Statistical analysis was performed by 2-
tailed unpaired Students t-test or two-way ANOVA as appropriate. A probability value 
of <0.05 was considered significant.  
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Results 
Time to thrombotic occlusion of the carotid artery was greatly decreased in 
stressed mice as compared to non-stressed controls (n=6, p<0.05, Figure 1A left), 
whereas initial carotid blood flow was comparable in both groups (Figure 1A middle). 
Chemical sympathectomy, attained by OHDA treatment, abrogated the pro-
thrombotic effect of stress as compared to vehicle treated stressed mice 
(F(1,20)=22.6, p<0.01, Figure 1A right).  
Blood-borne TF activity was increased in plasma of stressed mice as compared 
to non-stressed controls (F(1,16)=7.74, p<0.05) and this increase was prevented by 
OHDA treatment (F(1,16)=4.99, p=n.s., Figure 1B left). In contrast, TF activity (n=5, 
p=n.s., Figure 1B right) and expression (n=5, p=n.s., data not shown) in the vessel 
wall were similar in stressed mice and controls and remained unaffected by OHDA 
treatment.  
Platelet aggregation to thrombin remained unaffected by stress with or without 
OHDA treatment (n=5, p=n.s., Figure 1C left). Similarly, platelet count was not 
affected by stress with or without OHDA treatment (n=5, p=n.s., data not shown). 
Consistent with these observations, tail bleeding time was not affected by stress 
(n=5, p=0.57, Figure 1C middle). 
Activity of extrinsic and intrinsic coagulation pathway (PT and aPTT, 
respectively) exhibited no difference in plasma of stressed mice versus controls (PT: 
n=4-5, p=0.73; aPTT: n=4-5, p=0.48, Figure 1C right). The fibrinolytic system was 
examined by tPA expression in arterial homogenates and PAI-1 levels in plasma. 
Both tPA (0.16±0.03 vs. 0.11±0.02 tPA/S12, n=5, F(1,16)=0.29, p=0.20) and PAI-1 
(0.106±0.03 vs. 0.071±0.02 OD450, n=5, F(1,16)=8.39, p=0.36) remained unaffected 
by restraint stress.  
Blood pressure and heart rate were measured telemetrically. Within the first 
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hour of stress, a moderate increase in mean arterial blood pressure was observed in 
stressed as compared to control mice after 60 min (n=7-8, F(1,26)=8.23, p<0.05, 
Figure 2A and B). In OHDA treated mice, a similar, non-significant trend was 
observed in stressed mice as compared to the respective control mice. Values 
normalized after one hour resulting in a similar area under the curve in all the groups 
for systolic, diastolic, and mean arterial pressure as well as heart rate (n=7-8, p=n.s., 
Figure 2A). 
Noradrenaline (NA) levels were lower in plasma of OHDA treated non-stressed 
mice as compared to vehicle treated non-stressed mice (n=5, F(1,16)=8.50, p<0.05, 
Figure 2C). In stressed mice, the same treatment induced a tendency towards lower 
NA levels as well, but did not reach significance (n=5, p=n.s., Figure 2C). In both 
stressed and control mice, adrenaline (A) showed a trend towards higher levels in 
OHDA treated mice as compared to vehicle treated mice, reaching significance in 
stressed mice (n=5, F(1,26)=10.07, p<0.05, Figure 2C). Stress alone did not alter NA 
or A levels significantly (n=5, p=n.s., Figure 2C). 
TNF-α plasma levels remained unchanged after restraint stress as compared to 
controls (n=8, p=0.59, Figure 2D left). Stressed mice treated with etanercept revealed 
a similar decrease in occlusion time as stressed animals treated with vehicle (n=4, 
F(1,12)=0.06, p=n.s., Figure 2D right). Immunohistochemical analysis revealed 
unaltered levels of the macrophage marker CD68 in carotid arteries of stressed mice 
as compared to controls (1.4±0.4 vs. 0.4 ±0.16 stained cells/field, n=5, F(1,16)=1.75, 
p>0.05, Supplementary Figure) irrespective of OHDA treatment. Expression of the 
adhesion molecule VCAM-1 in carotid arteries of stressed mice was unchanged as 
compared to controls (6.6±1.2 vs. 3.2 ±0.78 % of area, n=5, F(1,16)=1.63, p>0.05, 
Supplementary Figure) irrespective of OHDA treatment. There was no CD3, P-
selectin, or E-selectin detectable in any of the samples.
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Discussion 
The INTERHEART study analyzed the relationship between stress and 
myocardial infarction in more than 10,000 cases and is in line with other reports 
showing a clear correlation between stress and acute myocardial infarction 
(Rosengren et al., 2004). Restraint stress, a long established experimental model to 
assess stress related responses in mice (Yamamoto et al., 2002), was used in this 
study to investigate in vivo the effects of stress on arterial thrombus formation, the 
key event in acute coronary syndromes (Ross, 1999). 
Stressed mice displayed a decreased time to thrombotic occlusion of the carotid 
artery, providing the first in vivo evidence for an increased prothrombotic potential as 
a direct response to stress.  
To assess the role of the SNS, chemical sympathectomy was attained using 
OHDA, which is known to induce degeneration of secondary sympathetic neurons. In 
vascular beds of rodents, destruction of adrenergic nerve endings has been shown to 
last for several weeks (Finch et al., 1972). OHDA pretreatment – completed 2 days 
before thrombosis experiments – prevented the effect of stress on arterial 
thrombosis, indicating a pivotal role of the SNS in mediating the stress-induced 
increase in arterial thrombus formation.  
TF, the main initiator of coagulation in vivo, is involved in the pathogenesis of 
arterial thrombus formation. Although it is predominantly known for its role in vascular 
smooth muscle cells, TF is also present in the circulating blood, referred to as blood-
borne TF. Blood borne TF is known to be biologically active (Bogdanov et al., 2003) 
and to originate from microparticles deriving from vascular smooth muscle cells, 
endothelial cells, and leucocytes as well as from the alternatively spliced soluble form 
(Steffel et al., 2006). We observed elevated TF activity in plasma of stressed mice, 
suggesting that blood-borne TF promotes the enhanced thrombus formation after 
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restraint stress. This increase in circulating TF was absent after chemical 
sympathectomy, hence dependent on the SNS. In contrast to these findings, we 
observed that TF activity and expression in the vessel wall of stressed mice remained 
unchanged. This differs from another study demonstrating that TF-mRNA was 
elevated in the adventitia of aortas from mice after restraint stress (Yamamoto et al., 
2002). This discrepancy most likely results from different dissection techniques, since 
the adventitial tissue, which is known to express high loads of TF, was removed from 
the vessels in the present study; furthermore, increased mRNA does not necessarily 
translate into an increased protein activity. 
Platelets play a crucial role in thrombus formation and were previously shown to 
be affected by specific stressors (Larsson et al., 1989). In the present study platelet 
count, platelet aggregation to thrombin, and tail bleeding time remained unaltered in 
stressed mice indicating that in this model, platelets are not a likely mediator of 
stress-enhanced arterial thrombosis. Plasma coagulation times (PT, representing the 
extrinsic, and aPTT, representing the intrinsic pathway of coagulation) as well as PAI-
1 levels in plasma and t-PA expression in the vessel wall remained unchanged by 
restraint stress, indicating that plasmatic coagulation and fibrinolysis were not 
affected either. In rats, PAI-1 was observed to increase within the first 3 hours of an 
immobilization stress protocol at the mRNA level (Ueyama et al., 2011). A transient 
increase in PA1-1 mRNA expression cannot be excluded in our mouse model, but 
did not translate into increased PAI-1 activity after 20 hours of restraint stress. 
In view of the major role of the SNS in stress as well as in regulating arterial 
blood pressure, previous studies suggested that changes in blood pressure may 
mediate stress-induced adverse cardiovascular events (Dimsdale, 2008). Therefore, 
blood pressure and heart rate were measured telemetrically throughout the stress 
protocol. The areas under the curve for systolic, diastolic, and mean blood pressure 
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as well as heart rate were comparable in all groups. Thus, we suggest that 
hemodynamic changes are unlikely to contribute to the enhanced thrombotic 
potential observed in stressed mice. The absence of relevant changes in blood 
pressure due to OHDA treatment may seem surprising considering the blockade of 
the SNS under such conditions. However, similar findings were previously reported 
and explained by enhanced excretion of A by the adrenal medulla compensating for 
reduced NA levels, thereby restoring blood pressure to normal values (De Champlain 
& Van Ameringen, 1972). In line with these previous findings, NA was reduced after 
OHDA treatment in the present study whilst A exhibited a trend towards higher 
plasma levels, reaching significance in stressed mice. The stress protocol itself had 
no influence on plasma catecholamine levels. In light of these observations, 
compensatory A excretion by the adrenal medulla may have prevented any major 
hemodynamic changes resulting from blockade of the SNS. 
Systemic inflammation (as assessed by TNF-α measurement in plasma and 
TNF-α inhibition by a soluble blocking receptor) as well as local inflammation (as 
assessed by immunohistochemical analysis of CD68, VCAM-1, CD3, P-selectin, and 
E-selectin expression in the arterial wall) revealed no changes in stressed mice. In 
view of the synopsis of these experiments, we conclude that inflammation does not 
contribute the observed acceleration in thrombus formation. 
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Conclusion 
We demonstrate that stress directly enhances arterial thrombosis in a controlled 
experimental setting. This effect is mediated through the SNS and at least in part by 
an increased activity of blood-born, but not vessel wall, TF. We cannot exclude that 
other parallel mechanisms contribute to the increased thrombotic response resulting 
from restraint stress and further studies will be needed to elucidate the molecular link 
between the SNS and the increase in plasma TF activity. Since high stress is a 
common feature characterizing modern societies, we are convinced that these novel 
findings may open future perspectives for the understanding of stress-induced 
cardiovascular events and thereby serve as a basis for clinical implications. 
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Figure Captions 
 Figure 1: A: Time to thrombotic occlusion of the carotid artery is decreased in 
mice after restraint stress (n=6, p<0.05, left). Initial carotid blood flow is comparable 
in both groups (middle). Chemical sympathectomy (OHDA treatment) blocks the 
effect of restraint stress on thrombotic occlusion (n=5, p=n.s., right). B: TF activity in 
plasma is increased in stressed mice as compared to controls (n=5, p<0.05, left). 
This increase is prevented by OHDA treatment (n=5, p=n.s., left). TF activity in the 
vessel wall is similar in stressed mice and controls irrespective of chemical 
sympathectomy (n=5, p=n.s., right). C: Platelet aggregation to thrombin remains 
unaltered by stress with or without chemical sympathectomy (n=5, p=n.s., left). Tail 
bleeding time (n=5, p=0.57, middle) as well as plasma activity of the extrinsic (PT) 
and intrinsic (aPTT) coagulation pathway are unaffected by stress (n=4-5, p=0.73 
and 0.48, respectively, right). 
 
Figure 2: A: Area under the curve is comparable in all the groups (n=7-8) for 
systolic, diastolic, and mean arterial blood pressure as well as heart rate. Full lines 
represent mean values of diastolic, mean and systolic blood pressure values; dashed 
lines represent mean heart rates. B: Mean arterial blood pressure was elevated in 
stressed as compared to control mice after 60 min (n=7-8, p<0.05). C: OHDA 
treatment induced lower plasma levels of noradrenaline in control mice and higher 
levels of adrenaline in stressed mice. Stress itself had no significant effect on 
catecholamine levels (n=5). D: TNF-α levels in plasma are unchanged by stress 
(n=8, p=0.59, left). Treatment with etanercept (Etan), a soluble blocking receptor for 
TNF-α, had no effect on stress-enhanced thrombus formation (n=4, p=n.s., right). 
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Supplementary Figure: 
Immunohistochemical staining (A: overview; B: detail): the macrophage marker 
CD68 and the adhesion molecule VCAM-1 were expressed to a similar extent in 
carotid arteries of stressed mice as compared to controls, irrespective of OHDA 
treatment; specific staining in red. 
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